SC1011

舒非尼酮

Report date: 2023/11/13 20:04:07
NME

Base Information

Drug NameSC1011
Drug Alias NameSC-1011JYP-1011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypersensitivityIdiopathic Pulmonary FibrosisPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShijiazhuang Zhikang Hongren New Drug Development Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Jiayue Pharmaceutical Technology Co LtdWuxi Zhikang Hongren New Drug Development Co LtdShijiazhuang Zhikang Hongren New Drug Development Co Ltd
Inactive CompaniesN/A
Active IndicationsHypersensitivityIdiopathic Pulmonary FibrosisPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A